Sat - Sun: Closed
Title Image

More Expansion! PT Pyridam Farma Tbk (PYFA) Acquisition of PT Ethica Industri Pharmaceuticals

More Expansion! PT Pyridam Farma Tbk (PYFA) Acquisition of PT Ethica Industri Pharmaceuticals

Jakarta, 13 June 2022 – After successfully acquiring PT Holi Pharma at the end of 2021, this time PT Pyridam Farma Tbk with the issuer code PYFA again signed an agreement with companies that are part of the Fresenius Kabi group in the context of the planned acquisition of 100% shares of PT Ethica Industri Pharmacy .

PT Ethica Industri Pharmacy is the first pharmaceutical company in Indonesia that has sterile technology with state-of-the-art facilities with a total area of ​​more than 52,000 m2. PT Ethica Industri Pharmacy also has a factory located in Jababeka with an area of ​​4.3 hectares which is equipped with high technology. In the construction of a factory in Jababeka itself, Fresenius Kabi has made an investment of 1 trillion to increase the production of injection drugs for people with critical and chronic illnesses in Indonesia.

“We are proud and honored to be able to sign an acquisition plan agreement with Fresenius Kabi as one of the world’s leading pharmaceutical companies who have trusted us to continue what we have built so far. The planned acquisition of PT Ethica will open up new opportunities with injection products and also strengthen Pyridam Farma Group’s position in the Indonesian pharmaceutical industry. “said Yenfrino Gunadi as Director of Pyridam Farma Group

In the future, Pyridam Farma Group will continue to innovate by establishing strategic partnerships with various industries to advance the healthcare industry in Indonesia and present innovator products and quality services for the Indonesian people.

About PT Pyridam Farma

PT Pyridam Farma Tbk is a pharmaceutical company whose main business is the production and/or distribution of modern and traditional medicines and the distribution of medical devices such as laboratory equipment and PCR test kits. The company was founded in 1976 and has been a public company and has been listed on the Indonesia Stock Exchange since 2001.

PT Pyridam Farma Tbk. produces various kinds of pharmaceutical products ranging from antibiotics, vitamins, health supplements, to traditional medicines. The company has more than 200 products in the form of effervescent tablets, caplets, capsules, syrups, and creams.
Prescription products registered by PT. Pyridam has several properties such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and various other indications which are divided into 12 therapeutic areas, as well as consumer products such as vitamins, antitussives, antipyretics and other supplements that can increase endurance.